Improving outcomes with better insights

Improving outcomes with better insights

Seamlessly integrating the workflow for the diagnosis and treatment of breast cancer.

Get in touch

Start using meaningful insights to deliver highly personalized healthcare

 

In recent decades, research and innovations have made the diagnosis and treatment of cancer more effective and personal. Sources like genomic testing, digital health solutions, advanced imaging, and applying analytics provide access to deep and broad patient-level data. They help us to focus on patients’ individual profiles and tailor care to their needs.

Watch this video to learn more


Discover our portfolio of integrated solutions for breast cancer care

Portfolio for breast cancer care
Anatomic pathology
 

Deliver diagnostic confidence, from stain to scan to analysis

Learn more

Genomic profiling

 

Select the workflow that matches your needs

Learn more

Data analysis

 

Empower your lab with actionable information

Learn more

Data integration

 

Support a personalized approach to healthcares

Learn more

Download a detailed overview of our solutions throughout the sample journey.

Sample journey

Get in touch


Would you like to know more about our integrated solutions, or do you have other questions? Leave your details and we will get in touch with you.

Matthias Bodmer

Matthias Bodmer

Disease Area Manager Oncology

Erfolg
Formular erfolgreich abgesendet
text

Learn more about personalized diagnostics

Aiming for higher ambition: the Roche approach to cracking the code of cancer

 

As patients become more knowledgeable, informed and tech savvy, the expectation for innovative and effective treatments increases. However, there is still a need to improve the quality of care in general. It is our ambition to meet and exceed both these demands. Read this article to learn how we do so.

Download our article to learn more

nature research
Companion diagnostics according to the FDA

 

“If the diagnostic test is inaccurate, then the treatment decision based on that test may not be optimal.” The American Food & Drug Administration (FDA) has been issuing guidances on companion diagnostics since 2014. Read their statement here to learn more about their approach.

Download our article to learn more

FDA

Learn more about personalized diagnostics

n1
Decrease trial-and-error medicine

 

Provide diagnostic tests to help identify patients most likely to respond to a specific treatment (Companion diagnostics).

n2
Increase the speed and accuracy of diagnosis

 

Improve patients’ chances of earlier and more specific treatments through more precise diagnostic and prognostic assessments.

n3
Decrease adverse drug reactions, including fatalities

 

Contribute to the development of safer treatments and help to avoid potential adverse events by identifying non-responders to a specific treatment.